INTC
33
-2
HSIC
56
5
WDC
47
4
NTAP
67
-3
VMC
57
4
DFS
64
2
DD
63
3
NSC
60
3
GT
62
6
JPM
69
2
CAH
48
-5
MCD
52
2
NDAQ
62
2
FTI
81
5
CRM
67
2
HAS
33
3
AN
58
4
AON
54
2
LNC
39
3
GS
75
2
INTC
33
-2
HSIC
56
5
WDC
47
4
NTAP
67
-3
VMC
57
4
DFS
64
2
DD
63
3
NSC
60
3
GT
62
6
JPM
69
2
CAH
48
-5
MCD
52
2
NDAQ
62
2
FTI
81
5
CRM
67
2
HAS
33
3
AN
58
4
AON
54
2
LNC
39
3
GS
75
2
Financhill
Back

Heron Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
15

HRTX
Heron Therapeutics

Last Price:
1.07
Seasonality Move:
17.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Heron Therapeutics Price Quote

$1.07

Heron Therapeutics Key Stats

Sell
15
Heron Therapeutics (HRTX) is a Sell
Day range:
$1.06 - $1.10
52-week range:
$1.04 - $3.93
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.18
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
-21.9%
Market cap:
$162.7M
Revenue:
$127M
EPS:
$-0.16

How Much Does Heron Therapeutics Make?

Is Heron Therapeutics Growing As A Company?

  • What Is Heron Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Heron Therapeutics Stock Price Performance

What Is Heron Therapeutics 52-Week High & Low?

Heron Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Heron Therapeutics?

  • How Much Debt Does Heron Therapeutics Have?
    Total long term debt quarterly is $174.5M
  • How Much Cash Does Heron Therapeutics Have?
    Cash and short term investments quarterly total is $70.9M
  • What Is Heron Therapeutics’s Book Value Per Share?
    Book value per share is -0.26

Is Heron Therapeutics Cash Flow Positive?

  • What Is HRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.3M
  • What Is Heron Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $716K
  • What Is Heron Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5M

Heron Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    HRTX return on invested capital is -20.08%
  • What Is Heron Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -12.62%
  • What Is HRTX Return On Equity?
    ROE is a measure of profitability and is 0%

Heron Therapeutics Earnings Date & Stock Price

Heron Therapeutics Competitors

  • Who Are Heron Therapeutics's Competitors?
    Below is a list of companies who compete with Heron Therapeutics or are related in some way:
    • Journey Medical Corp (DERM)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Heron Therapeutics Dividend Yield

Heron Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.29%
Revenue: 4.38% -11.16%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 460.75%

Major Shareholders

  • How many HRTX shares are owned by institutional investors?
    157M HRTX shares are owned by institutional investors
  • How many HRTX shares are owned by insiders?
    2.7M HRTX shares are owned by insiders